D-0835-2020 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0835-2020 was initiated by Pfizer Inc. on Feb 3, 2020 and is designated Class II. Reason for recall: Defective Container: confirmed customer reports for vials with loose metal overseal crimp defects, which may result in lack of assurance of sterility. The recall status is terminated (terminated Sep 29, 2022). Affected quantity: 38,676 trays.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Feb 3, 2020
Termination Date
Sep 29, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
38,676 trays

Product description

Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL), 2 mL Single-dose Vial, Each Tray contains 25 Vials, Intravenous or Intramuscular Use, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045, NDC 00409-9094-12 (vial), 00409-9094-22 (tray).

Reason for recall

Defective Container: confirmed customer reports for vials with loose metal overseal crimp defects, which may result in lack of assurance of sterility.

Distribution pattern

Nationwide in the U.S. and Puerto Rico

Code information

Lot #s: 08133DK (tray) 08-133-DK (vial); 08134DK (tray) 08-134-DK (vial), Exp. 2/1/2021.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0835-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0835-2020. Report a data issue: hello@regdatalab.com.